» Articles » PMID: 30266927

Three-Dimensional Retinal Organoids Facilitate the Investigation of Retinal Ganglion Cell Development, Organization and Neurite Outgrowth from Human Pluripotent Stem Cells

Overview
Journal Sci Rep
Specialty Science
Date 2018 Sep 30
PMID 30266927
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal organoids are three-dimensional structures derived from human pluripotent stem cells (hPSCs) which recapitulate the spatial and temporal differentiation of the retina, serving as effective in vitro models of retinal development. However, a lack of emphasis has been placed upon the development and organization of retinal ganglion cells (RGCs) within retinal organoids. Thus, initial efforts were made to characterize RGC differentiation throughout early stages of organoid development, with a clearly defined RGC layer developing in a temporally-appropriate manner expressing a complement of RGC-associated markers. Beyond studies of RGC development, retinal organoids may also prove useful for cellular replacement in which extensive axonal outgrowth is necessary to reach post-synaptic targets. Organoid-derived RGCs could help to elucidate factors promoting axonal outgrowth, thereby identifying approaches to circumvent a formidable obstacle to RGC replacement. As such, additional efforts demonstrated significant enhancement of neurite outgrowth through modulation of both substrate composition and growth factor signaling. Additionally, organoid-derived RGCs exhibited diverse phenotypes, extending elaborate growth cones and expressing numerous guidance receptors. Collectively, these results establish retinal organoids as a valuable tool for studies of RGC development, and demonstrate the utility of organoid-derived RGCs as an effective platform to study factors influencing neurite outgrowth from organoid-derived RGCs.

Citing Articles

Modelling human brain development and disease with organoids.

Birtele M, Lancaster M, Quadrato G Nat Rev Mol Cell Biol. 2024; .

PMID: 39668188 DOI: 10.1038/s41580-024-00804-1.


The application of retinal organoids in ophthalmic regenerative medicine: A mini-review.

Lan X, Jiang H, Wang Q, Shiqi Q, Xiong Y Regen Ther. 2024; 26:382-386.

PMID: 39050551 PMC: 11266866. DOI: 10.1016/j.reth.2024.06.013.


Brain organoid as a model to study the role of mitochondria in neurodevelopmental disorders: achievements and weaknesses.

Coronel R, Garcia-Moreno E, Siendones E, Barrero M, Martinez-Delgado B, Santos-Ocana C Front Cell Neurosci. 2024; 18:1403734.

PMID: 38978706 PMC: 11228165. DOI: 10.3389/fncel.2024.1403734.


A highly reproducible and efficient method for retinal organoid differentiation from human pluripotent stem cells.

Harkin J, Pena K, Gomes C, Hernandez M, Lavekar S, So K Proc Natl Acad Sci U S A. 2024; 121(25):e2317285121.

PMID: 38870053 PMC: 11194494. DOI: 10.1073/pnas.2317285121.


Landscape of human organoids: Ideal model in clinics and research.

Han X, Cai C, Deng W, Shi Y, Li L, Wang C Innovation (Camb). 2024; 5(3):100620.

PMID: 38706954 PMC: 11066475. DOI: 10.1016/j.xinn.2024.100620.


References
1.
Meyer J, Howden S, Wallace K, Verhoeven A, Wright L, Capowski E . Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells. 2011; 29(8):1206-18. PMC: 3412675. DOI: 10.1002/stem.674. View

2.
Sluch V, Davis C, Ranganathan V, Kerr J, Krick K, Martin R . Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line. Sci Rep. 2015; 5:16595. PMC: 4643248. DOI: 10.1038/srep16595. View

3.
Chen Y, Stevens B, Chang J, Milbrandt J, Barres B, Hell J . NS21: re-defined and modified supplement B27 for neuronal cultures. J Neurosci Methods. 2008; 171(2):239-47. PMC: 2678682. DOI: 10.1016/j.jneumeth.2008.03.013. View

4.
Stuermer C, Bastmeyer M . The retinal axon's pathfinding to the optic disk. Prog Neurobiol. 2000; 62(2):197-214. DOI: 10.1016/s0301-0082(00)00012-5. View

5.
Gill K, Hung S, Sharov A, Lo C, Needham K, Lidgerwood G . Enriched retinal ganglion cells derived from human embryonic stem cells. Sci Rep. 2016; 6:30552. PMC: 4978994. DOI: 10.1038/srep30552. View